Abstract:Klhl17 is associated with infantile spasms and autism spectrum disorders. However, the pathogenic mechanism remains elusive. This report shows that KLHL17 operates as a multifunctional adaptor to control dendritic spine enlargement via two mechanisms. One is by interacting with N‐ethylmaleimide‐sensitive fusion protein (NSF), which facilitates surface expression of α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptor (AMPAR) at dendritic spines. The other is by downregulating GluK2 expression upon neuronal activation, thereby controlling calcium influx and dendritic spine enlargement. These regulatory processes are likely relevant to the seizures and other neuronal phenotypes of patients suffering from KLHL17 deficiency. Kelch‐like family member 17 (KLHL17), an actin‐associated adaptor protein, is linked to neurological disorders, including infantile spasms and autism spectrum disorders. The key morphological feature of Klhl17‐deficient neurons is impaired dendritic spine enlargement, resulting in the amplitude of calcium events being increased. Our previous studies have indicated an involvement of F‐actin and the spine apparatus in KLHL17‐mediated dendritic spine enlargement. Here, we show that KLHL17 further employs different mechanisms to control the expression of two types of glutamate receptors, that is, α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptor (AMPAR) and kainate receptors (KARs), to regulate dendritic spine enlargement and calcium influx. We deployed proteomics to reveal that KLHL17 interacts with N‐ethylmaleimide‐sensitive fusion protein (NSF) in neurons, with this interaction of KLHL17 and NSF enhancing NSF protein levels. Consistent with the function of NSF in regulating the surface expression of AMPAR, Klhl17 deficiency limits the surface expression of AMPAR, but not its total protein levels. The NSF pathway also contributes to synaptic F‐actin distribution and the dendritic spine enlargement mediated by KLHL17. KLHL17 is known to act as an adaptor mediating degradation of the KAR subunit GluK2 by the CUL3 ubiquitin ligase complex, and Klhl17 deficiency impairs activity‐dependent degradation of GluK2. Herein, we further demonstrate that GluK2 is critical to the increased amplitude of calcium influx in Klhl17‐deficient neurons. Moreover, GluK2 is also involved in KLHL17‐regulated dendritic spine enlargement. Thus, our study reveals that KLHL17 controls AMPAR and KAR expression via at least two mechanisms, consequently regulating dendritic spine enlargement. The regulatory effects of KLHL17 on these two glutamate receptors likely contribute to neuronal features in patients suffering from certain neurological disorders.

Arf6-GEF BRAG1 regulates JNK-mediated synaptic removal of GluA1-containing AMPA receptors: a new mechanism for nonsyndromic X-linked mental disorder.

Pumping the Brakes: Suppression of Synapse Development by MDGA–neuroligin Interactions

GRASP1 Regulates Synaptic Plasticity and Learning through Endosomal Recycling of AMPA Receptors.

Neuronal ARHGAP8 controls synapse structure and AMPA receptor-mediated synaptic transmission

Dysfunction of AMPA receptor GluA3 is associated with aggressive behavior in human

Regulation of NMDA receptor trafficking and gating by activity-dependent CaMKIIα phosphorylation of the GluN2A subunit

Enhancing GluN2A-type NMDA receptors impairs long-term synaptic plasticity and learning and memory

N-terminal alternative splicing of GluN1 regulates the maturation of excitatory synapses and seizure susceptibility.

GSG1L Suppresses AMPA Receptor-Mediated Synaptic Transmission and Uniquely Modulates AMPA Receptor Kinetics in Hippocampal Neurons

Mutations in Ionotropic AMPA Receptor 3 Alter Channel Properties and Are Associated with Moderate Cognitive Impairment in Humans

AMPA Receptor GluA2 Subunit Defects Are a Cause of Neurodevelopmental Disorders

Autism-Associated Chromatin Regulator Brg1/SmarcA4 is Required for Synapse Development and Myocyte Enhancer Factor 2-Mediated Synapse Remodeling.

The GluA1 cytoplasmic tail regulates intracellular AMPA receptor trafficking and synaptic transmission onto dentate gyrus GABAergic interneurons, gating response to novelty

Ras Signaling Mechanisms Underlying Impaired GluR1-Dependent Plasticity Associated with Fragile X Syndrome

NMDARs Drive the Expression of Neuropsychiatric Disorder Risk Genes Within GABAergic Interneuron Subtypes in the Juvenile Brain

Early Expression of GluN2A-Containing NMDA Receptors in A Model of Fragile X Syndrome

Controlling of glutamate release by neuregulin3 via inhibiting the assembly of the SNARE complex.

Ubiquitination of the GluA1 Subunit of AMPA Receptors Is Required for Synaptic Plasticity, Memory, and Cognitive Flexibility

KLHL17 differentially controls the expression of AMPA‐ and KA‐type glutamate receptors to regulate dendritic spine enlargement

Inhibition of GluN2A NMDA receptors ameliorates synaptic plasticity deficits in the Fmr1-/y mouse model

MDGA2 Constrains Glutamatergic Inputs Selectively onto CA1 Pyramidal Neurons to Optimize Neural Circuits for Plasticity, Memory, and Social Behavior